<code id='49738AC193'></code><style id='49738AC193'></style>
    • <acronym id='49738AC193'></acronym>
      <center id='49738AC193'><center id='49738AC193'><tfoot id='49738AC193'></tfoot></center><abbr id='49738AC193'><dir id='49738AC193'><tfoot id='49738AC193'></tfoot><noframes id='49738AC193'>

    • <optgroup id='49738AC193'><strike id='49738AC193'><sup id='49738AC193'></sup></strike><code id='49738AC193'></code></optgroup>
        1. <b id='49738AC193'><label id='49738AC193'><select id='49738AC193'><dt id='49738AC193'><span id='49738AC193'></span></dt></select></label></b><u id='49738AC193'></u>
          <i id='49738AC193'><strike id='49738AC193'><tt id='49738AC193'><pre id='49738AC193'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:5
          Illustration of basket of food with prescription pad
          Molly Ferguson for STAT

          WASHINGTON — After nearly 40 years of obscurity, the “food is medicine” movement is having a moment.

          Multiple federal agencies are working on food is medicine projects, major organizations have pledged hundreds of millions in research funding, and billions more are being invested in food-focused startups. Even the White House has publicly announced its support for the movement, which focuses on the use of healthy food as a medical intervention for certain chronic and diet-related diseases.

          advertisement

          “We are at the inflection point,” said Dariush Mozaffarian, the dean for policy at the Tufts Friedman School of Nutrition Science and Policy. “Five or six years ago I would go to major health care organizations and talk about food [is] medicine and I’d get blank stares, crickets, and polite emails.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial
          FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

          MarkJ.Terrill/APAfollow-upstudyofafirst-of-its-kindcancertreatmentmayreflectsystemicbiases,theFoodan

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          CDC picks Alphabet's Verily for wasterwater surveillance contract

          AdobeAlphabet’slifesciencescompanyVerilyhasscoreditsfirstCentersforDiseaseControlandPreventioncontra